Sabaa Pharmaceutical turns to losses in 9 months: Egypt

Sabaa is an Egypt-based company engaged in the pharmaceutical sector

Staff Writer, Arab Finance

November 13, 2023

PHOTO

Sabaa International for Pharmaceutical and Chemical Industry (SIPC) incurred net losses after tax of EGP 3.881 million during the first nine months of 2023, versus net profits after tax amounting to EGP 488,979 during the same period in 2022, according to a November 12th disclosure filed to the Egyptian Exchange.

Revenues fell to EGP 8.426 million during the January-September period of this year from EGP 13.909 million during the first nine months of 2022.

Sabaa is an Egypt-based company engaged in the pharmaceutical sector. The company’s generic product portfolio includes products focused on different therapeutic categories.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.